Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;125(1):117-22.
doi: 10.1046/j.1365-2249.2001.01560.x.

Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS

Affiliations

Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS

M Di Renzo et al. Clin Exp Immunol. 2001 Jul.

Abstract

CVI is a primary immunodeficiency characterized by a failure of B cell differentiation associated with an array of T cell defects, such as enhanced T cell apoptosis. In this study we investigated the mechanisms underlying CVI enhanced T cell death. We analysed both the expression of Fas using flow cytometry techniques and the expression of FasL mRNA using RT-PCR in CVI T cells. We could not find any significant differences between CVI and normal subjects with regard to Fas expression, although there was a subgroup of CVI patients with very high Fas expression which was accompanied by an up-regulation of FasL mRNA. However, attempts to induce Fas-mediated apoptosis in these high Fas expressing cells, as evaluated by propidium iodide staining and APO2.7 staining, were unsuccessful. We also investigated intracellular levels of Bcl-2, bcl-xl and bax in CD4(+) and CD8(+) CVI T cells, as well as the bax/Bcl-2 ratio, using flow cytometry techniques but could not detect any differences between CVI and normal subjects. Finally we analysed TNF-RI and TNF-RII mRNA expression in CD4(+) and CD8(+) CVI T cells using semiquantitative RT-PCR and found a significant increase in expression of both TNF-Rs in CD4(+) T cells from CVI patients. Our data suggest that the increased expression of both TNF-Rs on T cells may be one of the mechanisms responsible for the accelerated T cell apoptosis in CVI.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Percentage of Fas expression on T cells from 40 CVI patients and 32 normal subjects. n.s. not significant. Horizontal lines represent the median values.
Fig. 2
Fig. 2
FasL mRNA expression in lymphocytes from six normal subjects (Nl) and eight CVI patients (P1-P8). + + positive control (PBMC cultured in the presence of PHA and IL2 for 4 days); C = negative control; MW = molecular weight marker.
Fig. 3
Fig. 3
TNF-RI and β-actin mRNA expression in CD4+ T cells from six CVI patients and six normal controls. N = negative control, M = molecular weight marker.
Fig. 4
Fig. 4
TNF-RII and β-actin mRNA expression in CD4+ T cells from six CVI patients and six normal controls. N = negative control, M = molecular weight marker.

References

    1. World Health Organization. Report of a WHO Scientific Group. Clin Exp Immunol. 1997;109(Suppl.1):1–28. - PubMed
    1. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48. - PubMed
    1. Bryant A, Calver NC, Toubi E, Webster ADB, Farrant J. Classification of patients with common variable immunodeficiency by B-cell secretion of IgM and IgG in response to anti-IgM and interleukin 2. Clin Immunol Immnopathol. 1990;56:239–48. - PubMed
    1. North ME, Spickett GP, Allsop L, Webster ADB, Farrant J. Defective DNA synthesis by T cells in acquired ‘common variable’ hypogammaglobulinemia on stimulation with mitogens. Clin Exp Immunol. 1989;76:19–23. - PMC - PubMed
    1. Baumert E, Wolff-Vorbeck G, Shlesier M, Peter HH. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency. Clin Exp Immunol. 1992;90:25–30. - PMC - PubMed

MeSH terms